Curapath, a leading innovator in the design and manufacturing of polymer and lipid-based drug delivery systems, is proud to announce a strategic partnership with Iris Biotech, a global distributor of specialty reagents for drug development and delivery. Through this collaboration, Iris Biotech will offer a broad selection of Curapath’s proprietary polymers, including polyaminoacids, polypeptoids, polyoxazolines, and their derivatives, for use in formulation, conjugation, encapsulation, and other advanced pharmaceutical applications.
Curapath’s polymers are developed and manufactured at its headquarters in Valencia, Spain, and are available in both R&D and GMP quality. These materials are designed to meet the growing demand for biocompatible, biodegradable, and customizable excipients in modern drug delivery systems, including lipid nanoparticles (LNPs), polymeric systems, and conjugates like polymer-drug systems or antibody drug conjugates (ADCs).
Among the highlights of this partnership is the availability of polyoxazolines and polysarcosines, versatile polymers classes offering a non-immunogenic alternative to PEG conferring stability, shielding and stealth functionalities to nanoformulations. These polymers provide comparable efficacy to PEGylated systems while addressing concerns related to PEG-associated immunogenicity and hypersensitivity reactions.
“Iris Biotech’s global reach and long-standing expertise in specialty reagents make them an ideal partner to expand access to our next-generation polymers,” said Victor de la Rosa, product manager at Curapath. “This collaboration empowers researchers and developers worldwide by providing straightforward access to our advanced materials in the creation of safer, more effective therapies.”
With this partnership, Iris Biotech strengthens its portfolio of cutting-edge materials for drug delivery, offering researchers a reliable source of high-quality polymers tailored for the evolving needs of pharmaceutical innovation.
You can find Curapath’s products on Iris Biotech website here: https://iris-biotech.de/global/drug-delivery.html
About Iris Biotech
Iris Biotech is providing high quality products for the fields peptide and nucleic acid synthesis, linkerology®, drug delivery, and life sciences in flexible quantities from research scale to commercial production, for academia as well as industry.
Besides the broad portfolio from standard to exotic, Iris Biotech has the know-how and facilities to manufacture the compound of choice based on a Custom Synthesis.
All the services are rounded off by a strong and competent personnel customer support.
Iris Biotech is in continuous exchange with scientists all around the world to gather ideas and be ahead regarding technologies and innovations true to the slogan Empowering Peptide Innovation.
Learn more at: https://iris-biotech.de/es/home
About Curapath
Curapath is a science-driven CDMO specializing in the design, development, and GMP manufacturing of advanced drug delivery systems. We support biopharma companies from early R&D through to commercial production, enabling innovation across every stage. With a strong expertise in nanoencapsulation and non-viral gene delivery, we offer polymer and lipid-based nanoparticles tailored for a wide variety of payloads. From excipient synthesis to drug product formulation, our flexible service model and proprietary technologies ensure a seamless path to the clinic. Committed to quality, innovation, and collaboration, we help bring next-generation therapies to market faster.
